{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:52:40Z","timestamp":1757627560523,"version":"3.44.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This study was financially supported by grants from the Medical University of Bialystok, Poland.","award":["B.SUB.25.427"],"award-info":[{"award-number":["B.SUB.25.427"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17430-2","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T21:22:54Z","timestamp":1756243374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Erythrocyte membrane lipid profile in children and adolescents with metabolic dysfunction-associated steatotic liver disease and insulin resistance: a preliminary study"],"prefix":"10.1038","volume":"15","author":[{"given":"Katarzyna","family":"Zdanowicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Harasim-Symbor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karol","family":"Sienkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata","family":"Wojtkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Janica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Flisiak-Jackiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Bobrus-Chociej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Chabowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariusz Marek","family":"Lebensztejn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"1","key":"17430_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/jpn3.12219","volume":"79","author":"BJ Perumpail","year":"2024","unstructured":"Perumpail, B. J. et al. The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis\/cirrhosis among adolescents\/young adults. J. Pediatr. Gastroenterol. Nutr. 79(1), 110\u2013118 (2024).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"4","key":"17430_CR2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.5114\/ceh.2023.133108","volume":"9","author":"K Zdanowicz","year":"2023","unstructured":"Zdanowicz, K. et al. Thrombospondin-2 as a potential noninvasive biomarker of hepatocyte injury but not liver fibrosis in children with MAFLD: A preliminary study. Clin. Exp. Hepatol. 9(4), 368\u2013374 (2023).","journal-title":"Clin. Exp. Hepatol."},{"issue":"4","key":"17430_CR3","first-page":"691","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher, G., Byrne, C. D. & Tilg, H. MASLD: A systemic metabolic disorder with cardiovascular and malignant complications. Gut 73(4), 691\u2013702 (2024).","journal-title":"Gut"},{"key":"17430_CR4","doi-asserted-by":"crossref","unstructured":"European Society for Pediatric Gastroenterology HpaNE, (EASL) EAftSotL, North American Society for Pediatric Gastroenterology Hp, and Nutrition (NASPGHAN), Latin\u2010American Society for Pediatric Gastroenterology Hp, and Nutrition (LASPGHAN), Asian Pan\u2010Pacific Society for Pediatric Gastroenterology HpaNA, (PASPGHAN) PASfPGaN et al. Paediatric steatotic liver disease has unique characteristics:\u00a0A multisociety statement endorsing the new nomenclature. J. Pediatr. Gastroenterol. Nutr. 78(5), pp. 1190\u20136 (2024).","DOI":"10.1002\/jpn3.12156"},{"issue":"9","key":"17430_CR5","doi-asserted-by":"publisher","first-page":"e2335511","DOI":"10.1001\/jamanetworkopen.2023.35511","volume":"6","author":"C Liu","year":"2023","unstructured":"Liu, C. et al. New-onset age of nonalcoholic fatty liver disease and cancer risk. JAMA Netw. Open 6(9), e2335511 (2023).","journal-title":"JAMA Netw. Open"},{"issue":"8","key":"17430_CR6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti, E., Pinzani, M. & Tsochatzis, E. A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65(8), 1038\u20131048 (2016).","journal-title":"Metabolism"},{"key":"17430_CR7","doi-asserted-by":"publisher","first-page":"1061524","DOI":"10.3389\/fendo.2022.1061524","volume":"13","author":"VM Tagi","year":"2022","unstructured":"Tagi, V. M., Samvelyan, S. & Chiarelli, F. An update of the consensus statement on insulin resistance in children 2010. Front. Endocrinol. 13, 1061524 (2022).","journal-title":"Front. Endocrinol."},{"key":"17430_CR8","doi-asserted-by":"publisher","first-page":"111541","DOI":"10.1016\/j.nut.2021.111541","volume":"94","author":"N Kopiczko","year":"2022","unstructured":"Kopiczko, N. et al. Serum concentration of fatty acids in children with obesity and nonalcoholic fatty liver disease. Nutrition 94, 111541 (2022).","journal-title":"Nutrition"},{"issue":"7","key":"17430_CR9","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1210\/clinem\/dgae028","volume":"109","author":"M N\u00fa\u00f1ez-S\u00e1nchez","year":"2024","unstructured":"N\u00fa\u00f1ez-S\u00e1nchez, M. et al. Lipidomic analysis reveals alterations in hepatic FA profile associated with MASLD stage in patients with obesity. J. Clin. Endocrinol. Metab. 109(7), 1781\u20131792 (2024).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"17430_CR10","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3390\/biomedicines10051201","volume":"10","author":"R Ventura","year":"2022","unstructured":"Ventura, R., Mart\u00ednez-Ruiz, I. & Hern\u00e1ndez-Alvarez, M. I. Phospholipid membrane transport and associated diseases. Biomedicines 10(5), 1201 (2022).","journal-title":"Biomedicines"},{"issue":"1\u20132","key":"17430_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0163-7827(00)00017-5","volume":"40","author":"L Lauritzen","year":"2001","unstructured":"Lauritzen, L., Hansen, H. S., J\u00f8rgensen, M. H. & Michaelsen, K. F. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog. Lipid Res. 40(1\u20132), 1\u201394 (2001).","journal-title":"Prog. Lipid Res."},{"issue":"4","key":"17430_CR12","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/ejcn.2014.18","volume":"68","author":"S Jacobs","year":"2014","unstructured":"Jacobs, S. et al. Association between erythrocyte membrane fatty acids and biomarkers of dyslipidemia in the EPIC-potsdam study. Eur. J. Clin. Nutr. 68(4), 517\u2013525 (2014).","journal-title":"Eur. J. Clin. Nutr."},{"issue":"9","key":"17430_CR13","doi-asserted-by":"publisher","first-page":"e106912","DOI":"10.1371\/journal.pone.0106912","volume":"9","author":"P Koehrer","year":"2014","unstructured":"Koehrer, P. et al. Erythrocyte phospholipid and polyunsaturated fatty acid composition in diabetic retinopathy. PLoS ONE 9(9), e106912 (2014).","journal-title":"PLoS ONE"},{"issue":"8","key":"17430_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1089\/met.2015.0025","volume":"13","author":"G Colussi","year":"2015","unstructured":"Colussi, G., Catena, C., Mos, L. & Sechi, L. A. The metabolic syndrome and the membrane content of polyunsaturated fatty acids in hypertensive patients. Metab. Syndr. Relat. Disord. 13(8), 343\u2013351 (2015).","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"11","key":"17430_CR15","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.3390\/nu12113446","volume":"12","author":"I Jauregibeitia","year":"2020","unstructured":"Jauregibeitia, I. et al. Fatty acid profile of mature red blood cell membranes and dietary intake as a new approach to characterize children with overweight and obesity. Nutrients 12(11), 3446 (2020).","journal-title":"Nutrients"},{"issue":"5","key":"17430_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/jpm11050337","volume":"11","author":"I Jauregibeitia","year":"2021","unstructured":"Jauregibeitia, I. et al. Potential of erythrocyte membrane lipid profile as a novel inflammatory biomarker to distinguish metabolically healthy obesity in children. J. Pers. Med. 11(5), 337 (2021).","journal-title":"J. Pers. Med."},{"issue":"1","key":"17430_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/metabo11010043","volume":"11","author":"I Jauregibeitia","year":"2021","unstructured":"Jauregibeitia, I. et al. Molecular differences based on erythrocyte fatty acid profile to personalize dietary strategies between adults and children with obesity. Metabolites 11(1), 43 (2021).","journal-title":"Metabolites"},{"issue":"2","key":"17430_CR18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00394-018-1677-2","volume":"58","author":"S Bonafini","year":"2019","unstructured":"Bonafini, S. et al. Individual fatty acids in erythrocyte membranes are associated with several features of the metabolic syndrome in obese children. Eur. J. Nutr. 58(2), 731\u2013742 (2019).","journal-title":"Eur. J. Nutr."},{"issue":"12","key":"17430_CR19","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00232-013-9596-x","volume":"246","author":"JS Perona","year":"2013","unstructured":"Perona, J. S., Gonz\u00e1lez-Jim\u00e9nez, E., Aguilar-Cordero, M. J., Sureda, A. & Barcel\u00f3, F. Structural and compositional changes in erythrocyte membrane of obese compared to normal-weight adolescents. J. Membr. Biol. 246(12), 939\u2013947 (2013).","journal-title":"J. Membr. Biol."},{"issue":"8","key":"17430_CR20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3390\/nu16081205","volume":"16","author":"SJ Pang","year":"2024","unstructured":"Pang, S. J. et al. The association between the plasma phospholipid profile and insulin resistance: A population-based cross-section study from the China adult chronic disease and nutrition surveillance. Nutrients 16(8), 1205 (2024).","journal-title":"Nutrients"},{"issue":"10","key":"17430_CR21","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1053\/meta.2002.35184","volume":"51","author":"M Younsi","year":"2002","unstructured":"Younsi, M. et al. Erythrocyte membrane phospholipid composition is related to hyperinsulinemia in obese nondiabetic women: Effects of weight loss. Metabolism 51(10), 1261\u20131268 (2002).","journal-title":"Metabolism"},{"issue":"2","key":"17430_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S0026-0495(00)91455-0","volume":"49","author":"JN Clore","year":"2000","unstructured":"Clore, J. N. et al. Changes in phosphatidylcholine fatty acid composition are associated with altered skeletal muscle insulin responsiveness in normal man. Metabolism 49(2), 232\u2013238 (2000).","journal-title":"Metabolism"},{"issue":"1","key":"17430_CR23","doi-asserted-by":"publisher","first-page":"6531","DOI":"10.1038\/s41598-018-24976-x","volume":"8","author":"S Lee","year":"2018","unstructured":"Lee, S. et al. Skeletal muscle phosphatidylcholine and phosphatidylethanolamine respond to exercise and influence insulin sensitivity in men. Sci. Rep. 8(1), 6531 (2018).","journal-title":"Sci. Rep."},{"issue":"1","key":"17430_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1039\/D0FO02092C","volume":"12","author":"Q Yu","year":"2021","unstructured":"Yu, Q. et al. High n-3 fatty acids counteract hyperglycemia-induced insulin resistance in fat-1 mice via pre-adipocyte NLRP3 inflammasome inhibition. Food Funct. 12(1), 230\u2013240 (2021).","journal-title":"Food Funct."},{"key":"17430_CR25","doi-asserted-by":"publisher","first-page":"8848161","DOI":"10.1155\/2021\/8848161","volume":"2021","author":"AH Mariamenatu","year":"2021","unstructured":"Mariamenatu, A. H. & Abdu, E. M. Overconsumption of omega-6 polyunsaturated fatty acids (PUFAs) versus deficiency of omega-3 PUFAs in modern-day diets: The disturbing factor for their \u201cbalanced antagonistic metabolic functions\u201d in the human body. J. Lipids. 2021, 8848161 (2021).","journal-title":"J. Lipids."},{"issue":"1","key":"17430_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12944-017-0552-0","volume":"16","author":"M Notarnicola","year":"2017","unstructured":"Notarnicola, M. et al. Significant decrease of saturation index in erythrocytes membrane from subjects with non-alcoholic fatty liver disease (NAFLD). Lipids Health Dis. 16(1), 160 (2017).","journal-title":"Lipids Health Dis."},{"key":"17430_CR27","doi-asserted-by":"publisher","first-page":"5856201","DOI":"10.1155\/2018\/5856201","volume":"2018","author":"D Maciejewska","year":"2018","unstructured":"Maciejewska, D. et al. Changes of the fatty acid profile in erythrocyte membranes of patients following 6-month dietary intervention aimed at the regression of nonalcoholic fatty liver disease (NAFLD). Can. J. Gastroenterol. Hepatol. 2018, 5856201 (2018).","journal-title":"Can. J. Gastroenterol. Hepatol."},{"issue":"6","key":"17430_CR28","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78(6), 1966\u20131986 (2023).","journal-title":"Hepatology"},{"issue":"1","key":"17430_CR29","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.1152\/ajpendo.00645.2007","volume":"294","author":"R Muniyappa","year":"2008","unstructured":"Muniyappa, R., Lee, S., Chen, H. & Quon, M. J. Current approaches for assessing insulin sensitivity and resistance in vivo: Advantages, limitations, and appropriate usage. Am. J. Physiol. Endocrinol. Metab. 294(1), E15-26 (2008).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"17430_CR30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3889\/oamjms.2018.097","volume":"6","author":"M Kostovski","year":"2018","unstructured":"Kostovski, M., Simeonovski, V., Mironska, K., Tasic, V. & Gucev, Z. Metabolic profiles in obese children and adolescents with insulin resistance. Open Access Maced. J. Med. Sci. 6(3), 511\u2013518 (2018).","journal-title":"Open Access Maced. J. Med. Sci."},{"issue":"8","key":"17430_CR31","doi-asserted-by":"publisher","first-page":"102581","DOI":"10.1016\/j.dsx.2022.102581","volume":"16","author":"DL Tahapary","year":"2022","unstructured":"Tahapary, D. L. et al. Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride\/glucose index. Diabetes Metab. Syndr. 16(8), 102581 (2022).","journal-title":"Diabetes Metab. Syndr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17430-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17430-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17430-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T03:56:21Z","timestamp":1757476581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17430-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17430"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17430-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"6 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31511"}}